S100A11 and lung carcinoma: Zagresjzzaya et al. [24] found that low S100A11 expression promoted reactive oxygen species- (ROS-) dependent cell apoptosis through the activation of phospholipase A2 (PLA2), thereby enhancing the sensitivity of lung cancer cells to cisplatin, 5-fluorouracil, and oxaliplatin.